PDL BioPharma Analysis
PDL BioPharma is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of PDL BioPharma delisted stock analysis is to determine its intrinsic value, which is an estimate of what PDL BioPharma is worth, separate from its market price. There are two main types of PDL BioPharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect PDL BioPharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of PDL BioPharma's stock to identify patterns and trends that may indicate its future price movements.
The PDL BioPharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. PDL BioPharma is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. PDL Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and PDL BioPharma's ongoing operational relationships across important fundamental and technical indicators.
PDL |
PDL Stock Analysis Notes
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PDL BioPharma has Price/Earnings (P/E) ratio of 526.67. The entity recorded a loss per share of 1.32. The firm last dividend was issued on the 2nd of June 2016. PDL BioPharma had 2:1 split on the 10th of October 2001. PDL BioPharma, Inc. manages various patents in the United States and internationally. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada. PDL BioPharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 109 people. To find out more about PDL BioPharma contact John McLaughlin at 775 832-8500 or learn more at www.pdl.com.PDL BioPharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. PDL BioPharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding PDL BioPharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| PDL BioPharma is not yet fully synchronised with the market data | |
| PDL BioPharma has some characteristics of a very speculative penny stock | |
| PDL BioPharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 27.76 M. Net Loss for the year was (39.18 M) with profit before overhead, payroll, taxes, and interest of 13.43 M. | |
| PDL BioPharma currently holds about 105.45 M in cash with (56.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93. | |
| Over 97.0% of the company shares are owned by institutional investors |
PDL Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 282.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PDL BioPharma's market, we take the total number of its shares issued and multiply it by PDL BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding PDL BioPharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in PDL Stock
If you are still planning to invest in PDL BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PDL BioPharma's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |